- Poster presentation
- Open Access
Continuous renal replacement therapy with the adsorbent membrane oXiris in septic patients: a clinical experience
Critical Care volume 17, Article number: P63 (2013)
Renal failure is an important complication of sepsis and CRRT with adsorbing membranes may be useful in this clinical setting . The aims of the study in septic/septic shock patients are to evaluate: the safety of a new hemofilter membrane oXiris with adsorbing properties and anti-endotoxin activity; the renal and hemodynamic response; and the changes of endotoxin and proinflammatory molecules.
Forty septic/septic shock patients with renal failure were enrolled in the study. All patients had preoperative endotoxin >0.6 level/units (EAA Spectral D) and were submitted to high-volume hemodiafiltration (50 ml/kg/hour, Prismaflex; Gambro) with a new treated heparin-coated membrane (oXiris; Gambro). At T0 (pre-treatment) and T1 (24 hours) the main clinical and biochemical data were evaluated. All data are expressed as mean ± SD. One-way ANOVA test with Bonferroni correction was used to evaluate the data changes. P < 0.05 was considered significant.
Table 1 presents the main results of this study.
In septic/septic shock patients with renal failure, CRRT with a new treated heparin-coated membrane (oXiris; Gambro) is clinically feasible, and has a positive effect on renal function and hemodynamics. An adsorbing effect on proinflammatory mediators may have a role in these results. These data and the trend toward a decrease of endotoxin during the treatment warrant further investigation.
Rimmelé T, et al.: Nephrol Dial Transplant. 2009, 24: 421-427.
About this article
Cite this article
Turani, F., Candidi, F., Barchetta, R. et al. Continuous renal replacement therapy with the adsorbent membrane oXiris in septic patients: a clinical experience. Crit Care 17, P63 (2013). https://doi.org/10.1186/cc12001
- Renal Failure
- Replacement Therapy
- Bonferroni Correction
- Renal Replacement Therapy
- ANOVA Test